Akums Drugs & Pharma started trading on the BSE at Rs 725.00, which is 46 points or 6.77% higher than its issue price of Rs 679.00.

Currently, the stock is trading at Rs 762.65, marking an increase of 83.65 points or 12.32% from its issue price.

The stock has reached a high of Rs 784.65 and a low of Rs 724.50 so far. A total of 5.96 lakh shares have been traded.

The public offering, open for subscription from July 30, 2024, to August 1, 2024, was subscribed 63.56 times. The issue price was set at Rs 679.00 per share, the upper limit of the price band of Rs 646-679 per share.

Akums Drugs and Pharmaceuticals, a CDMO, provides a wide array of pharmaceutical products and services both domestically and internationally.